TLR9 agonist immunomodulator treatment of cutaneous T-cell lymphoma (CTCL) with CPG7909. 46th Annual Meeting of the American-Society-of-Hematology Kim, Y., Girardi, M., Duvic, M., Kuzel, T., Rook, A., Link, B., Pinter-Brown, L., Comerci, C., McAuley, S., Schmalbach, T. AMER SOC HEMATOLOGY. 2004: 212A–213A

View details for Web of Science ID 000225127500745